Canmax Technologies Co

Canmax Technologies Co Debt/EBITDA

The Total Debt to EBITDA Ratio of Canmax Technologies Co (300390.SZ) as of Oct 22, 2026 is 1.43. In the previous year, Total Debt to EBITDA Ratio was 1.05 — a change of 35.75% (higher).

Debt/EBITDA

1.43

YoY

35.75%

Last updated:

Total Debt to EBITDA Ratio of Canmax Technologies Co is 2024 1.43 . Total Debt to EBITDA Ratio of Canmax Technologies Co was 2023 1.05 . It decreases by 35.75% higher compared to the previous year.

The Canmax Technologies Co Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2017
0.65 CNY
Jan 1, 2018
1.45 CNY
Jan 1, 2019
1.00 CNY
Jan 1, 2020
1.70 CNY
Jan 1, 2021
0.98 CNY
Jan 1, 2022
0.34 CNY
Jan 1, 2023
1.05 CNY
Jan 1, 2024
1.43 CNY
The Canmax Technologies Co Debt/EBITDA history
YEARDebt/EBITDAYoY
1.43+35.75%
1.05+210.47%
0.34-65.31%
0.98-42.37%
1.70+69.25%
1.00-30.84%
1.45+122.03%
0.65-71.62%
2.30+301.65%
0.57+25.25%
0.46—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Canmax Technologies Co Stock analysis

What does Canmax Technologies Co do? Canmax Technologies Co., Ltd. generates revenue through three core business segments. The Anti-static Ultra-clean Product segment sells human body protection systems, process protection systems, and environmental protection systems for cleanroom and ESD control. The Medical Device Product segment offers self-destruction syringes, safety syringes, and high pressure syringes. The Lithium Battery Material Product segment focuses on battery-grade lithium hydroxide, covering R&D, production, and sales. Domestic and overseas markets are the primary sales channels for all product lines. The company's customers include manufacturers requiring cleanroom solutions, healthcare providers needing medical devices, and battery producers seeking lithium hydroxide. These segments serve distinct industries: cleanroom and ESD control for electronics manufacturing, medical devices for healthcare, and battery materials for energy storage. The firm's product portfolio targets specific industrial needs within these sectors. Revenue streams are derived from the sale of anti-static ultra-clean products, medical devices, and lithium hydroxide. The Anti-static Ultra-clean Product segment supports electronics manufacturing with specialized systems, while the Medical Device Product segment caters to healthcare safety standards. The Lithium Battery Material Product segment meets demand for battery-grade lithium hydroxide in the growing energy storage market. Canmax Technologies Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Canmax Technologies Co stock

Total Debt to EBITDA Ratio of Canmax Technologies Co is 1.43 in 2024.

Total Debt to EBITDA Ratio of Canmax Technologies Co changed from 1.05 to 1.43, representing a 35.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Canmax Technologies Co since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Canmax Technologies Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Canmax Technologies Co

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Canmax Technologies Co